Shkreli's Former Company KaloBios Files for Bankruptcy

Updated on
  • Biotech company aims to restructure, salvage leukemia drug
  • KaloBios saw `imminent threat' after Shkreli's arrest

Martin Shkreli Case Holds Mirror to Pharma Business

KaloBios Pharmaceuticals Inc., which Martin Shkreli rescued from liquidation last month, filed for bankruptcy after his arrest knocked the biotechnology company’s brief revival off course.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.